REV3L and cutaneous squamous cell carcinoma: Their study revealed that PICSAR lncRNA sponges miR-485-5p in cisplatin-resistant cutaneous squamous cell carcinoma cells, which leads to REV3L overexpression and resistance of the cancerous cells to cisplatin.